WisdomTree BioRevolution Fund
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.45
資產淨值: 327.07
成立日期: 01/06/2021
 
分析
市值分佈:
51.77%
大市值
17.25%
中市值
3.50%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 13/06/2026 05:51) 總持有投資項目: 68  
0%
 
100%
     10大 (27.29%)
代號 名稱 佔比% 持有日期
NVSEFNovartis AG1.4630/04/2026
AGIOAgios Pharmaceuticals1.3830/04/2026
VRTXVertex Pharmaceuticals1.3330/04/2026
SGEN1.2330/11/2023
TXG10x Genomics1.2130/04/2026
BHVNBiohaven Ltd1.0330/04/2026
EDITEditas Medicine1.0230/04/2026
VBVBFVERBIO SE1.0030/04/2026
EXELExelixis0.9930/04/2026
CLDXCelldex Therapeutics0.9930/04/2026
CGONCG Oncology0.9830/04/2026
ALLOAllogene Therapeutics0.9730/04/2026
PTGXProtagonist Therapeutics0.9630/04/2026
VCYTVeracyte0.9530/04/2026
ARGXargenx SE0.9130/04/2026
FMCFMC Corp0.9030/04/2026
CGEMCullinan Therapeutics0.8730/04/2026
INSMInsmed Incorporated0.8630/04/2026
ABSIAbsci Corp0.8530/04/2026
ARCTArcturus Therapeutics Holdings0.8230/04/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.